Home›Search›Onkourologiya

Onkourologiya

ABV-press Publishing House · Russian Federation · Est. 2009

ISSN1996-1812

SJR Q4✓ WOS ESCI✓ Scopus / SJR

Removed from DOAJ (2023-02-06). DOAJ's stated reason: Journal is not open access. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q4. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.126

H-Indexi

SNIPi

0.097

Total Worksi

808

Total Citationsi

1,019

2yr Mean Citednessi

0.21

Open Impact Factor alternative

Aims & Scope

Scientific and practical reviewed quarterly color journal. Target audience: oncourologists, urologists, oncologists, RCOU members, chemotherapists, radiation oncologists, surgeons, experts of the large pharmaceutical companies. Content: lectures, researches, case examples, leading specialists comments, reviews, discussion materials, reports on activities in the field of oncological urology.

General Information

Country / RegionRussian Federation

Primary LanguageRussian

1st Year Published2009

FrequencyQuarterly

StatusActive (last: 2025)

Total Publications808

Publisher OrgABV-press

OA Since2014

Visit Journal Website

Submission Info

Peer ReviewPeer-reviewed

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

7/11 · 64%

✅

Do you know the journal / publisher?

ABV-press Publishing House

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1996-1812

✅

Indexed in a trusted database?

WoS, Scopus

✅

Peer review process documented?

Peer-reviewed

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

Russian

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

164

2019

112

2020

112

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

NephrologyQ4

OncologyQ4

Radiology, Nuclear Medicine and ImagingQ4

SurgeryQ4

UrologyQ4

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Radiology, Nuclear Medicine and ImagingNephrologySurgeryUrologyOncology

Research Topics (OpenAlex)

Prostate Cancer Treatment and ResearchRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsProstate Cancer Diagnosis and TreatmentRenal and related cancersUrinary and Genital Oncology StudiesMultiple and Secondary Primary CancersUrological Disorders and TreatmentsRadiopharmaceutical Chemistry and ApplicationsCancer Immunotherapy and Biomarkers

Frequently asked questions about Onkourologiya

Is Onkourologiya a predatory journal?

Onkourologiya was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal is not open access" (2023-02-06). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Onkourologiya?

Onkourologiya is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.21.

Is Onkourologiya indexed in Scopus and Web of Science?

Onkourologiya is indexed in Web of Science, Scopus.